Insider · CIK 0001298079
Brazzell Romulus K
Reports to the SEC for 2 companies · DURHAM, NC
Transactions
50
Companies
2
Filings
9
CIK
0001298079
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-10-22 | KALAKALA BIO, Inc.S Sale | −$38.8K |
| 2025-06-24 | KALAKALA BIO, Inc.S Sale | −$21.1K |
| 2025-06-03 | KALAKALA BIO, Inc.S Sale | −$13.8K |
| 2025-01-06 | KALAKALA BIO, Inc.A Award | — |
| 2025-01-06 | KALAKALA BIO, Inc. · Stock Option (right to buy)A Award | — |
| 2025-01-06 | KALAKALA BIO, Inc.S Sale | −$18.7K |
| 2024-06-26 | KALAKALA BIO, Inc.S Sale | −$26.1K |
| 2024-05-31 | KALAKALA BIO, Inc.S Sale | −$12.2K |
| 2024-01-04 | KALAKALA BIO, Inc. · Stock Option (right to buy)A Award | — |
| 2024-01-04 | KALAKALA BIO, Inc.S Sale | −$10.9K |
| 2024-01-04 | KALAKALA BIO, Inc.A Award | — |
| 2023-06-22 | KALAKALA BIO, Inc.A Award | — |
| 2023-06-22 | KALAKALA BIO, Inc. · Stock Option (right to buy)A Award | — |
| 2023-05-31 | KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-05-31 | KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-05-31 | KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-05-31 | KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-05-31 | KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-05-31 | KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-05-31 | KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-05-31 | KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-05-31 | KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2023-05-31 | KALAKALA BIO, Inc.A Award | — |
| 2023-03-14 | KALAKALA BIO, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-01-04 | KALAKALA BIO, Inc.S Sale | −$2,082.69 |
| 2023-01-04 | KALAKALA BIO, Inc.A Award | — |
| 2022-10-26 | KALAKALA BIO, Inc.S Sale | −$1,699.11 |
| 2022-06-27 | KALAKALA BIO, Inc.S Sale | −$1,163.28 |
| 2022-01-04 | KALAKALA BIO, Inc.S Sale | −$4,555.2 |
| 2022-01-03 | KALAKALA BIO, Inc. · Stock Option (right to buy)A Award | — |
| 2021-10-26 | KALAKALA BIO, Inc.S Sale | −$23K |
| 2021-06-28 | KALAKALA BIO, Inc.S Sale | −$17.5K |
| 2021-01-04 | KALAKALA BIO, Inc.A Award | — |
| 2021-01-04 | KALAKALA BIO, Inc. · Stock Option (right to buy)A Award | — |
| 2020-10-26 | KALAKALA BIO, Inc.A Award | — |
| 2020-06-25 | KALAKALA BIO, Inc.A Award | — |
| 2020-04-09 | KALAKALA BIO, Inc.M Exercise/Conversion | +$42K |
| 2020-04-09 | KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2020-04-09 | KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2020-04-09 | KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2020-04-09 | KALAKALA BIO, Inc.M Exercise/Conversion | +$159K |
| 2020-04-09 | KALAKALA BIO, Inc.M Exercise/Conversion | +$1,278.4 |
| 2020-01-02 | KALAKALA BIO, Inc. · Stock Option (right to buy)A Award | — |
| 2019-01-02 | KALAKALA BIO, Inc. · Stock Option (right to buy)A Award | — |
| 2018-02-07 | KALAKALA BIO, Inc. · Stock Option (right to buy)A Award | — |
| 2017-08-11 | KALAKALA BIO, Inc.M Exercise/Conversion | +$24.5K |
| 2017-08-11 | KALAKALA BIO, Inc.M Exercise/Conversion | +$11K |
| 2017-08-11 | KALAKALA BIO, Inc.M Exercise/Conversion | +$102K |
| 2017-08-11 | KALAKALA BIO, Inc.M Exercise/Conversion | +$40.6K |
| 2017-08-11 | KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
Recent filings
- 4Brazzell Romulus K0001298079-25-000003SEC(opens sec.gov)
- 4Brazzell Romulus K0001415889-25-018318SEC(opens sec.gov)
- 4Brazzell Romulus K0001415889-25-015678SEC(opens sec.gov)
- 4Brazzell Romulus K0001415889-25-001061SEC(opens sec.gov)
- 4Brazzell Romulus K0001415889-24-018373SEC(opens sec.gov)
- 4Brazzell Romulus K0001415889-24-015223SEC(opens sec.gov)
- 4Brazzell Romulus K0001415889-24-000770SEC(opens sec.gov)
- 4Brazzell Romulus K0001415889-23-010284SEC(opens sec.gov)
- 4Brazzell Romulus K0001415889-23-009135SEC(opens sec.gov)
Companies
Address
C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200
DURHAM, NC, 27703